Standout Papers

Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer 2009 2026 2014 2020 760
  1. Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer (2009)
    Matthew Smith, Blair Egerdie et al. New England Journal of Medicine
  2. Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them (2014)
    Paul L. Nguyen, Shabbir M.H. Alibhai et al. European Urology

Immediate Impact

1 by Nobel laureates 9 from Science/Nature 79 standout
Sub-graph 1 of 19

Citing Papers

Prostate Cancer
2025 Standout
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
1 intermediate paper

Works of Matthew Smith being referenced

ERA 223: A phase 3 trial of radium-223 dichloride (Ra-223) in combination with abiraterone acetate (abiraterone) and prednisone in the treatment of asymptomatic or mildly symptomatic chemotherapy-naïve patients (pts) with bone predominant metastatic castration-resistant prostate cancer (mCRPC).
2015
Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
2014 Standout

Author Peers

Author Last Decade Papers Cites
Matthew Smith 2191 2679 1211 59 4.2k
Matthew R. Smith 3274 2873 1366 69 5.3k
Joseph F. Simeone 1234 3369 1568 68 5.5k
Richard Cowan 2361 1023 763 134 5.1k
Matthew R. Smith 5114 3397 1542 119 7.4k
Ingo Diel 1164 4954 1575 111 6.3k
RE Coleman 1886 2374 2084 170 6.0k
Francis J. McGovern 4333 1553 1018 89 6.4k
Peyman Hadji 906 3787 802 166 5.6k
Janet E. Brown 2388 5262 1964 150 6.9k
Alexander Paterson 1094 3907 1460 102 4.9k

All Works

Loading papers...

Rankless by CCL
2026